Reinert J, Beitzen-Heineke A, Wethmar K, Stelljes M, et al. Loss of CD22 expression and expansion of a CD22(dim) subpopulation in adults with relapsed/refractory B-lymphoblastic leukaemia after treatment with Inotuzumab-Ozogamicin. Ann Hematol 2021;100:2727-2732.
PMID: 34331563